Sanil Bhatia

24PUBLICATIONS
120CO-AUTHORS
Separation technologiesHaematological tumoursPharmacogenomicsInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 10, 2026
Rapid Two-Step Multicomponent Synthesis and Structure-degradation Relationships of Selective HDAC6 PROTAC Degraders.

|Aug 10, 2026
Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic Leukemia.

|Jul 14, 2026
Targeting Histone Acetyltransferases EP300/CBP by Novel Proline-Based PROTAC Degraders.

|Mar 07, 2026
Epigenetic remodeling via HDAC6 inhibition amplifies anti-tumoral immune responses in myeloid leukemia cells.

Julian Schliehe-Diecks, Jia-Wey Tu, Pawel Stachura

|Jan 02, 2026
Discovery of Histone Deacetylase 8-Specific Proteolysis-Targeting Chimeras with Anticancer Activity against Hematological Malignancies.

Shiyang Zhai, Marie Kemkes, Cindy-Esther Kponomaizoun

|Dec 23, 2025
Small-molecule inhibitor of C‑terminal HSP90 dimerization modulates autophagy and functions synergistically with mTOR inhibition to kill cisplatin-resistant cancer cells.

Céline David, Yadong Sun, Vitalij Woloschin

Pageof 4

Frequent Collaborators

10 joint publications

Finn K Hansen

8 joint publications

Arndt Borkhardt

5 joint publications

Thomas Kurz

5 joint publications

Holger Gohlke